Sign in
4

Changes in Ownership

Maze Therapeutics, Inc. Filed Acc 0001415889-25-022301

Options or other derivatives

  • Director acquired 16,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Exter Neil Director 2025-08-17 Grant or award · Stock Option (Right to Buy) +16,000 16,000 D: show line 1 in the form
Loading xslF345X05/form4-08192025_080831.xml…